Tag: chemistry
-
Joint Venture to Develop Stable RNA Covid-19 Vaccine
A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine.
-
Infographic – Post-Covid CO2 Emissions Rebound
As the world’s economy recovers from pandemic restrictions, rising carbon dioxide emissions are also contributing to the global climate crisis.
-
Alphabet Forms AI Drug Discovery Company
Alphabet, the parent company of Google, is forming a new enterprise using artificial intelligence techniques to discover new protein-based drugs.
-
Synthetic Protein Company Gains $25M in New Funds
A company designing engineered proteins to work better than natural chemistries as treatments for disease is raising $25 million in its first venture round.
-
Gene Therapy Delivery Company Gains $26M in Early Funds
A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round.
-
Delivery Tech Licensed for CBD Epilepsy Nasal Spray
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain.
-
Pharma, Synthetic Bio Companies to Find Antibody Therapies
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases.
-
Trial Shows Synthetic Antibody Slows Cognitive Decline
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease.
-
Nasal Spray Shown to Stop Covid-19 Infection, Disease
An antiviral nasal spray is shown in tests with lab mice to prevent infection from SARS-CoV-2 viruses and reduce disease-causing cytokines.
-
RNA Manufacturer Goes Public in $282M Merger
A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition.